Wei Liu

17PUBLICATIONS
51CO-AUTHORS
Economic models and forecastingMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Mar 30, 2026
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.

Yuting Yan, Weihao Chen, Ying Yu

|Mar 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Ying Yu, Yuxi Li, Rui Cui

|Mar 07, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Wenjie Xiong, Yuting Yan, Tingyu Wang

|Oct 07, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.

Yuting Yan, Ying Yu, Wenjie Xiong

|Oct 01, 2024
C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study.

Ping Li, Wei Liu, Lili Zhou

Pageof 3

Frequent Collaborators

9 joint publications

Jianxiang Wang

7 joint publications

Gang An

6 joint publications

Dehui Zou

5 joint publications

Rui Lyu